CytoSorbents Corp (NAS:CTSO)
$ 0.9676 0.1013 (11.69%) Market Cap: 52.55 Mil Enterprise Value: 61.55 Mil PE Ratio: 0 PB Ratio: 2.77 GF Score: 58/100

Cytosorbents Corporation - Special Call Transcript

Apr 03, 2020 / 05:00PM GMT
Release Date Price: $6.73 (-12.03%)
Operator

Good afternoon. Thank you for attending the Cowen conference call with Josh Jennings and the CEO of CytoSorbents, Dr. Phillip Chan.

The contents of this call and the views expressed on it are solely for the use of Cowen and Company clients. Any publication, reproduction or transmission of this information without the express permission of Cowen is expressly prohibited. As a reminder, we are not interested in receiving and you should not disclose any confidential information. In the event that you inadvertently disclose such information, please notify us as soon as possible.

I would now like to pass the conference over to your host, Josh Jennings with Cowen. Thank you. You may proceed, Mr. Jennings.

Joshua Thomas Jennings
Cowen and Company, LLC, Research Division - MD & Senior Research Analyst

Thanks, operator, and good morning -- sorry, good afternoon, everyone. Thank you for dialing in and joining for this call, which is part of the Cowen COVID-19 Virtual Conference series. We have Dr. Phil Chan, the CEO of CytoSorbents. Phil, thanks so

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot